Literature DB >> 8650157

A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide.

M B Yim1, J H Kang, H S Yim, H S Kwak, P B Chock, E R Stadtman.   

Abstract

Cu,Zn-superoxide dismutase (SOD) is known to be a locus of mutation in familial amyotrophic lateral sclerosis (FALS). Transgenic mice that express a mutant Cu,Zn-SOD, Gly-93--> Ala (G93A), have been shown to develop amyotrophic lateral sclerosis (ALS) symptoms. We cloned the FALS mutant, G93A, and wild-type cDNA of human Cu,Zn-SOD, overexpressed them in Sf9 insect cells, purified the proteins, and studied their enzymic activities for catalyzing the dismutation of superoxide anions and the generation of free radicals with H2O2 as substrate. Our results showed that both enzymes contain one copper ion per subunit and have identical dismutation activity. However, the free radical-generating function of the G93A mutant, as measured by the spin trapping method, is enhanced relative to that of the wild-type enzyme, particularly at lower H2O2 concentrations. This is due to a small, but reproducible, decrease in the value of Km for H2O2 for the G93A mutant, while the kcat is identical for both enzymes. Thus, the ALS symptoms observed in G93A transgenic mice are not caused by the reduction of Cu,Zn-SOD activity with the mutant enzyme; rather, it is induced by a gain-of-function, an enhancement of the free radical-generating function. This is consistent with the x-ray crystallographic studies showing the active channel of the FALS mutant is slightly larger than that of the wild-type enzyme; thus, it is more accessible to H2O2. This gain-of-function, in part, may provide an explanation for the association between ALS and Cu,Zn-SOD mutants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8650157      PMCID: PMC39125          DOI: 10.1073/pnas.93.12.5709

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Copper, zinc superoxide dismutase catalyzes hydroxyl radical production from hydrogen peroxide.

Authors:  M B Yim; P B Chock; E R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 2.  Motor neurone disease and animal models.

Authors:  D L Price; D W Cleveland; V E Koliatsos
Journal:  Neurobiol Dis       Date:  1994-11       Impact factor: 5.996

3.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

4.  Electrostatic recognition between superoxide and copper, zinc superoxide dismutase.

Authors:  E D Getzoff; J A Tainer; P K Weiner; P A Kollman; J S Richardson; D C Richardson
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

5.  Examination of the role of arginine-143 in the human copper and zinc superoxide dismutase by site-specific mutagenesis.

Authors:  W F Beyer; I Fridovich; G T Mullenbach; R Hallewell
Journal:  J Biol Chem       Date:  1987-08-15       Impact factor: 5.157

6.  The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: chemiluminescence and peroxidation.

Authors:  E K Hodgson; I Fridovich
Journal:  Biochemistry       Date:  1975-12-02       Impact factor: 3.162

7.  Affinity inactivation of bovine Cu,Zn superoxide dismutase by hydroperoxide anion, HO2-.

Authors:  H J Fuchs; C L Borders
Journal:  Biochem Biophys Res Commun       Date:  1983-11-15       Impact factor: 3.575

8.  Brain glutamate deficiency in amyotrophic lateral sclerosis.

Authors:  T L Perry; S Hansen; K Jones
Journal:  Neurology       Date:  1987-12       Impact factor: 9.910

9.  Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; G Tsai; R W Kuncl; L Clawson; D R Cornblath; D B Drachman; A Pestronk; B L Stauch; J T Coyle
Journal:  Ann Neurol       Date:  1990-07       Impact factor: 10.422

10.  Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid.

Authors:  T L Perry; C Krieger; S Hansen; A Eisen
Journal:  Ann Neurol       Date:  1990-07       Impact factor: 10.422

View more
  84 in total

1.  Negative regulation of the gene for Fe-containing superoxide dismutase by an Ni-responsive factor in Streptomyces coelicolor.

Authors:  H J Chung; J H Choi; E J Kim; Y H Cho; J H Roe
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

2.  Contrasting, species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein.

Authors:  Anthony R White; Gerd Multhaup; Denise Galatis; William J McKinstry; Michael W Parker; Rüdiger Pipkorn; Konrad Beyreuther; Colin L Masters; Roberto Cappai
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

Review 3.  Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.

Authors:  Lee J Martin; Qing Chang
Journal:  Mol Neurobiol       Date:  2011-11-10       Impact factor: 5.590

4.  Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients.

Authors:  P I Oteiza; O D Uchitel; F Carrasquedo; A L Dubrovski; J C Roma; C G Fraga
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

Review 5.  Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.

Authors:  Lee J Martin
Journal:  IDrugs       Date:  2010-08

6.  Identification of the prooxidant site of human ceruloplasmin: a model for oxidative damage by copper bound to protein surfaces.

Authors:  C K Mukhopadhyay; B Mazumder; P F Lindley; P L Fox
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

7.  Peroxynitrite nitrates adenine nucleotide translocase and voltage-dependent anion channel 1 and alters their interactions and association with hexokinase II in mitochondria.

Authors:  Meiying Yang; Yanji Xu; James S Heisner; Jie Sun; David F Stowe; Wai-Meng Kwok; Amadou K S Camara
Journal:  Mitochondrion       Date:  2018-11-01       Impact factor: 4.160

Review 8.  Mutant CuZn superoxide dismutase in motor neuron disease.

Authors:  M E Gurney; R Liu; J S Althaus; E D Hall; D A Becker
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

9.  Management of oxidative stress in the CNS: the many roles of glutathione.

Authors:  B H Juurlink
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

10.  Enhanced free radical generation of FALS-associated Cu,Zn-SOD mutants.

Authors:  M B Yim; H S Yim; P B Chock; E R Stadtman
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.